NEW YORK (GenomeWeb News) – NextGen has entered the gene-synthesis market after licensing Gene Oracle's GeneIOS gene-synthesis products and services, NextGen said today.
 
Under the agreement, NextGen will incorporate the GeneIOS technology into a new generation of ContractExpress products. The company will offer the combined technology as part of its fee-for-service offering.
 
NextGen will also offer GeneIOS as a standalone gene-synthesis product in the gene-to-protein development market.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.